Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Mar 29:17:167.
doi: 10.1186/s13063-016-1298-0.

Effects of indexes of consciousness (IoC1 and IoC2) monitoring on remifentanil dosage in modified radical mastectomy: a randomized trial

Guisheng Wu  1   2 , Lei Zhang  2 , Xuxiang Wang  2 , Ailan Yu  2 , Zongwang Zhang  2 , Jingui Yu  3
Affiliations
Randomized Controlled Trial

Effects of indexes of consciousness (IoC1 and IoC2) monitoring on remifentanil dosage in modified radical mastectomy: a randomized trial

Guisheng Wu et al. Trials. .

Abstract

Background: This study investigated the effects of indexes of consciousness (IoC1 and IoC2) monitoring on remifentanil dosage.

Methods: In this randomized, single-blinded, prospective study, 120 patients undergoing unilateral modified radical mastectomy were randomly assigned to the treatment group (T group, n = 60) or control group (C group, n = 60). In the T group, patients received both IoC1 (sedation) and IoC2 (analgesia) monitoring, and remifentanil dosages were adjusted by anesthetists according to IoC2. In the C group, remifentanil dosages were adjusted based on the anesthetists' judgment according to the patients' vital signs. Remifentanil dose, adjustment frequency, infusion duration, intraoperative adverse events, and quality of anesthetic recovery were compared between the two groups. The primary outcome was the dose of remifentanil.

Results: Compared with the C group, mean remifentanil dosage was significantly higher in the T group (3.8 ± 1.9 versus 3.2 ± 1.2 μg kg(-1) h(-1), P < 0.05) during the anesthetic period, as was the adjustment frequency of target-controlled infusion (2.9 ± 1.9 versus 2.0 ± 1.2 times/surgery, P < 0.05), but there was no difference in infusion duration. Voluntary eye opening, extubation time, and recovery score were not significantly different between the two groups (P > 0.05). Total adverse events were significantly reduced in the T group (P < 0.05).

Conclusions: IoC1-targeted propofol dosing does not seem to be significantly different to hemodynamic-based monitoring, whereas IoC2 monitoring can increase remifentanil dosage during modified radical mastectomy, but the anesthetic process is more controllable and total adverse events are reduced, which improves the controllability of anesthesia.

Trial registration number: ChiCTR-TRC-13004101 , registered on 27 November 2013.

Keywords: Index of consciousness; IoC2 monitoring; Propofol; Remifentanil; Unilateral modified radical mastectomy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Consort patients flow diagram
See this image and copyright information in PMC

References

    1. De Jonckheere J, Bonhomme V, Jeanne M, Boselli E, Gruenewald M, Logier R, et al. Physiological signal processing for individualized anti-nociception management during general anesthesia: a review. Yearb Med Inform. 2015;10:95–101. doi: 10.15265/IY-2015-004. - DOI - PMC - PubMed
    1. Jensen EW, Valencia JF, Lopez A, Anglada T, Agusti M, Ramos Y, et al. Monitoring hypnotic effect and nociception with two EEG-derived indices, qCON and qNOX, during general anaesthesia. Acta Anaesthesiol Scand. 2014;58:933–41. doi: 10.1111/aas.12359. - DOI - PubMed
    1. Kempen PM. Let us make MRI anesthesia safe! Anesth Analg. 2007;104:1602. doi: 10.1213/01.ane.0000260550.53813.64. - DOI - PubMed
    1. Mashour GA, Shanks A, Tremper KK, Kheterpal S, Turner CR, Ramachandran SK, et al. Prevention of intraoperative awareness with explicit recall in an unselected surgical population: a randomized comparative effectiveness trial. Anesthesiology. 2012;117:717–25. doi: 10.1097/ALN.0b013e31826904a6. - DOI - PMC - PubMed
    1. Bruhn J, Myles PS, Sneyd R, Struys MM. Depth of anaesthesia monitoring: what's available, what's validated and what's next? Br J Anaesth. 2006;97:85–94. doi: 10.1093/bja/ael120. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources